TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Active Biotech AB (publ)
Closing information (x1000 EUR)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
0
|
0
|
670 |
| Financial expenses |
48
|
6
|
15 |
| Earnings before taxes |
-5,245
|
-4,872
|
-3,212 |
| EBITDA |
-5,202
|
-4,868
|
-3,219 |
| Total assets |
4,583
|
5,554
|
3,203 |
| Current assets |
3,965
|
5,462
|
3,017 |
| Current liabilities |
1,084
|
968
|
932 |
| Equity capital |
3,101
|
4,564
|
2,203 |
| - share capital |
123
|
110
|
75 |
| Employees (average) |
9
|
8
|
10 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
67.7%
|
82.2%
|
68.8% |
| Turnover per employee |
0
|
0
|
67 |
| Profit as a percentage of turnover | -479.4% | ||
| Return on assets (ROA) |
-113.4%
|
-87.6%
|
-99.8% |
| Current ratio |
365.8%
|
564.3%
|
323.7% |
| Return on equity (ROE) |
-169.1%
|
-106.7%
|
-145.8% |
| Change turnover |
0
|
-658
|
-169 |
| Change turnover % |
-100%
|
-20% | |
| Chg. No. of employees |
1
|
-2
|
-2 |
| Chg. No. of employees % |
13%
|
-20%
|
-17% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.